SCHEMBL5376256

SCHEMBL5376256

C=CC(=O)N1CCC(Cc2ccccc2)CC1c1cc2cc(C(N)=O)ccc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
GRIN2B Q13224 2/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2C Q14957 1/20 0.42
GRIN3A Q8TCU5 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
TNKS O95271 1/20 0.41
PARP1 P09874 1/20 0.41
PARP14 Q460N5 1/20 0.41
ACHE P22303 1/20 0.41
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CHEK1 O14757 1/20 0.39
F2 P00734 2/20 0.39
OPRM1 P35372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5372920 0.82 GRIN2B (0.45) GAAGRIN2BGRIN2DGRIN3BGRIN1
SCHEMBL5203581 0.74 GAA (0.54) GAAGRIN2BGRIN2DGRIN3BGRIN1
SCHEMBL5374216 0.73 GAA (0.46) GAAGRIN2BGRIN2DGRIN3BGRIN1
SCHEMBL5374221 0.73 GAA (0.46) GAAGRIN2BGRIN2DGRIN3BGRIN1
SCHEMBL5732647 0.73 GAA (0.48) GAAGRIN2BGRIN2DGRIN3BGRIN1
SCHEMBL5376247 0.71 GAA (0.41) GAAGRIN2BGRIN2DGRIN3BGRIN1
SCHEMBL5368021 0.70 GAA (0.48) GAAGRIN2BTNKSPARP1PARP14
SCHEMBL5372866 0.69 GAA (0.52) GAAGRIN2BGRIN2DGRIN3BGRIN1
SCHEMBL24076760 0.68 SLC6A2 (0.69) SLC6A2SLC6A4
SCHEMBL30301388 0.68 SLC6A2 (0.69) SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed